The Unexpected Victim Of America’s Ozempic Boom

Retailers are reporting a disturbing new trend affecting their bottom line, and they strongly suspect it has something to do with customers using GLP-1 drugs. According to the Wall Street Journal, businesses are noticing a higher return rate, which is being chalked up to people losing weight and needing to purchase smaller sizes. The number ...